Carbonic anhydrase IX and acid transport in cancer
HM Becker - British journal of cancer, 2020 - nature.com
Alterations in tumour metabolism and acid/base regulation result in the formation of a hostile
environment, which fosters tumour growth and metastasis. Acid/base homoeostasis in …
environment, which fosters tumour growth and metastasis. Acid/base homoeostasis in …
Hybrid nanoparticle composites applied to photodynamic therapy: strategies and applications
Photodynamic therapy (PDT), as a robust strategy, has long been applied to cancer
treatment owing to the meaningful breakthroughs and unique advantages, including …
treatment owing to the meaningful breakthroughs and unique advantages, including …
Exploitation of elevated extracellular ATP to specifically direct antibody to tumor microenvironment
F Mimoto, K Tatsumi, S Shimizu, S Kadono, K Haraya… - Cell reports, 2020 - cell.com
The extracellular adenosine triphosphate (ATP) concentration is highly elevated in the tumor
microenvironment (TME) and remains tightly regulated in normal tissues. Using phage …
microenvironment (TME) and remains tightly regulated in normal tissues. Using phage …
Efficient uptake and retention of iron oxide-based nanoparticles in HeLa cells leads to an effective intracellular delivery of doxorubicin
RC Popescu, D Savu, I Dorobantu, BS Vasile… - Scientific reports, 2020 - nature.com
The purpose of this study was to construct and characterize iron oxide nanoparticles
(IONPCO) for intracellular delivery of the anthracycline doxorubicin (DOX; IONPDOX) in …
(IONPCO) for intracellular delivery of the anthracycline doxorubicin (DOX; IONPDOX) in …
A survey of biological building blocks for synthetic molecular communication systems
Synthetic molecular communication (MC) is a new communication engineering paradigm
which is expected to enable revolutionary applications such as smart drug delivery and real …
which is expected to enable revolutionary applications such as smart drug delivery and real …
Biomolecules-assisted synthesis of degradable bismuth nanoparticles for dual-modal imaging-guided chemo-photothermal therapy
C Liu, L Zhang, X Chen, S Li, Q Han, L Li… - Chemical Engineering …, 2020 - Elsevier
To avoid toxicity of multifunctional nanomaterials in bioapplication, the biodegradable
inorganic nanoparticles (NPs) must be our main focus. In the work, we firstly developed …
inorganic nanoparticles (NPs) must be our main focus. In the work, we firstly developed …
Recent advances of D-α-tocopherol polyethylene glycol 1000 succinate based stimuli-responsive nanomedicine for cancer treatment
Y Guan, L Wang, B Wang, M Ding, Y Bao, S Tan - Current medical science, 2020 - Springer
D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) is a pharmaceutical excipient
approved by Chinese NMPA and FDA of USA. It's widely applied as a multifunctional drug …
approved by Chinese NMPA and FDA of USA. It's widely applied as a multifunctional drug …
Transport metabolons and acid/base balance in tumor cells
HM Becker, JW Deitmer - Cancers, 2020 - mdpi.com
Solid tumors are metabolically highly active tissues, which produce large amounts of acid.
The acid/base balance in tumor cells is regulated by the concerted interplay between a …
The acid/base balance in tumor cells is regulated by the concerted interplay between a …
Fibrinolytic tissue plasminogen activator installed redox-active nanoparticles (t-PA@ iRNP) for cancer therapy
T Mei, B Shashni, H Maeda, Y Nagasaki - Biomaterials, 2020 - Elsevier
Favorable blood flow within solid tumors has become the principal strategy for drug delivery.
The use of thrombolytic drugs, such as tissue plasminogen activator (t-PA), in combination …
The use of thrombolytic drugs, such as tissue plasminogen activator (t-PA), in combination …
Strategies for altering lipid self-assembly to trigger liposome cargo release
While liposomes have proven to be effective drug delivery nanocarriers, their therapeutic
attributes could be improved through the development of clinically viable triggered release …
attributes could be improved through the development of clinically viable triggered release …